Divis Laboratories Board Meeting on Aug 1 to Approve Q1 FY27 Results

Divis Laboratories Ltd has announced that its Board of Directors will convene on August 1, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Concurrently, the trading window for the company's securities, which was closed from July 1, 2026, will remain shut until 48 hours after the declaration of these financial results, extending its closure until August 3, 2026.